Table 1 Literature review of reported cases of IgA vasculitis with renal involvement during TNF inhibitor therapy. ANA: anti-nuclear antibodies; CS: corticosteroids; CYC: cyclophosphamide; MMF: mycophenolate mofetil; N/A: not available
From: Rituximab as possible therapy in TNF inhibitor-induced IgA vasculitis with severe renal involvement
Author, year | Number of cases | TNF inhibitor | Serology positivity | Withdrawal of TNF inhibitor | Treatment | Outcome |
|---|---|---|---|---|---|---|
Duffy et al., 2006 [14] | 1 | Etanercept | ANA | Yes | CS, CYC | Good response |
Sokumbi et al., 2012 [15] | 1 | Infliximab | N/A | Yes | CS, MMF | No response |
Rolle et al., 2013 [16] | 1 | Etanercept | ANA, anti-histone | Yes | CS | Good response |
Hokama et al., 2019 [17] | 1 | Adalimumab | Negative tests | Yes | CS | Good response |
Fukuda et al., 2023 [18] | 1 | Infliximab | N/A | Yes | CS | Good response |